A cheaper, safer CBD alternative? Scientists discover new synthetic CBD analogue alleviates seizures in rats

Findings of the study are the basis of a new start-up, Syncanica, which is developing commercial applications of the new H2CBD compound

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

08 Aug 2019 --- Dixie Botanicals, a subsidiary of Medical Marijuana, Inc. – the first-ever publicly traded cannabis company in the US and specialist in marijuana-derived... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

02 Aug 2019 --- In nutrition news this week, Dutch-based Tradin Organic announced that it is offering a wide variety of “Organic Keto-friendly Ingredients” and tapping... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

01 Aug 2019 --- Exposure to delta-9-tetrahydrocannabinol (THC), the principal psychoactive cannabinoid found in cannabis, can induce inflammation and oxidative stress, which are... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

31 Jul 2019 --- Cannabidiol (CBD) attenuates the aggressiveness induced by social isolation, a Brazilian study has concluded. As one of the first studies to investigate the impact... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

26 Jul 2019 --- US-based CBD-infused food and beverage producer, Weller, has closed a US$3 million funding round led by Brand Foundry Ventures, a venture capital firm that invests... Read More

trans